Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
188.86
+0.29 (+0.15%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
68
69
Next >
Nearing Retirement? These Stocks Will Pay You For Life
August 29, 2023
These companies are passive income machines.
Via
The Motley Fool
Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price Cuts
August 29, 2023
The Biden administration is planning to negotiate the prices of 10 drugs in 2026.
Via
Investor's Business Daily
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
August 29, 2023
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point.
Via
Benzinga
7 Stocks to Buy for the Rest of 2023
August 29, 2023
With the stock market off to a bombastic start, these top stocks for 2023 are worth betting on for the remainder of the year
Via
InvestorPlace
Late-Summer Steals: 7 Stocks to Buy Before Fall
August 28, 2023
With the summer season coming to an end and investors returning from vacation, it’s time to consider these stocks to buy now.
Via
InvestorPlace
Looking Into AbbVie's Recent Short Interest
August 22, 2023
Via
Benzinga
This Is What Whales Are Betting On AbbVie
August 21, 2023
Via
Benzinga
1 High-Yield Dividend Stock That Looks Like a Screaming Buy
August 17, 2023
Look beyond the company's near-term headwinds.
Via
The Motley Fool
3 Surprisingly Underrated Stocks to Buy Right Now
August 26, 2023
These stocks deserve more respect than they're getting.
Via
The Motley Fool
Boeing's 737 Deliveries Delay Due To Supplier Spirit Aerosystems, Petco Health and Wellness Stock Tumbles, AstraZeneca Under Legal Lens: Today's Top Stories
August 24, 2023
Benzinga
Via
Benzinga
Topics
Supply Chain
Exposures
Boeing 737
Supply Chain
Cheaper Version Of Blockbuster Arthritis Treatment Humira - CVS Health Teams With Sandoz
August 24, 2023
CVS Health Corp (NYSE: CVS) has launched Cordavis, a wholly-owned subsidiary, to work directly with manufacturers to commercialize and/or co-produce biosimilar
Via
Benzinga
7 Very Oversold High-Yield Stocks to Buy Right Now
August 23, 2023
For speculators wanting to gamble the conservative way, these oversold high-yield stocks to buy may be what you’re looking for.
Via
InvestorPlace
AbbVie Unusual Options Activity For August 11
August 11, 2023
Via
Benzinga
This Is What Whales Are Betting On AbbVie
August 09, 2023
Via
Benzinga
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
August 09, 2023
Via
Benzinga
7 Top Dividend Stocks for Income and Stability
August 21, 2023
With strong fundamentals and long track records of dividend growth, these are the top seven dividend stocks to buy.
Via
InvestorPlace
Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner
August 21, 2023
Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years.
Via
Talk Markets
Trillion-Dollar Trio: These 3 Super Growth Stocks Will Dominate the Market by 2035
August 17, 2023
As companies naturally continue to expand and the stock market grows, trillion-dollar valuations will be a more common occurrence.
Via
InvestorPlace
7 Blue-Chip Stocks Smart Investors Should Be Loading Up on Now
August 14, 2023
These shares of blue-chip stocks to buy continue to be attractive for smart investors who value strong firms and steady performance.
Via
InvestorPlace
7 Dividend Stocks to Buy as Investor Sentiment Falters
August 14, 2023
With economic uncertainty rising, investors can ride out the potential storm with these dividend stocks to buy.
Via
InvestorPlace
How Revance Is Taking A Page Out Of AbbVie's Botox Playbook
August 14, 2023
The company sells a cosmetic treatment. Now, it's bridging into neuroscience.
Via
Investor's Business Daily
My Top Dividend King to Buy and Hold for the Next 10 Years, and It Isn't Even Close
August 14, 2023
This stock offers a high dividend yield, impressive dividend growth, and a lot more.
Via
The Motley Fool
3 Unstoppable Dividend Stocks to Buy Right Now
August 12, 2023
These stocks' dividends are more dependable than most.
Via
The Motley Fool
3 Pharma Stocks to Sell in August Before They Crash and Burn
August 11, 2023
Stay far away from these pharma stocks that are suffering from declining sales and weak pipelines of future products.
Via
InvestorPlace
5 Best Stocks to Buy in a Bear Market
August 11, 2023
Want income-producing assets and stable stocks? Look for stocks with stable cash flow in rock-solid industries for the best stocks to buy in a bear market.
Via
MarketBeat
Topics
Economy
Exposures
Economy
3 Pharmaceutical Stocks to Buy and Hold for the Long Haul
August 11, 2023
Robust pipelines make these three pharmaceutical stocks solid choices for investors looking for stocks to buy and hold for long-term gains
Via
MarketBeat
Exposures
COVID-19
3 Stocks That Recently Raised Their Guidance for the Year
August 09, 2023
These businesses have rosier outlooks for the future -- but that doesn't mean they're all slam-dunk buys right now.
Via
The Motley Fool
3 AI Stocks You’ll Regret Not Buying Soon
August 08, 2023
AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.
Via
InvestorPlace
Why Shares of Enanta Pharmaceuticals Are Dropping Tuesday
August 08, 2023
The company saw a slight revenue decline in its fiscal 2023 third-quarter earnings report.
Via
The Motley Fool
Is AbbVie Still a Good Dividend Stock to Buy?
August 08, 2023
Find out if AbbVie can overcome sinking sales of its top-selling product.
Via
The Motley Fool
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
68
69
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.